122 related articles for article (PubMed ID: 982341)
1. Pyridinolcarbamate in the long-term treatment of ischaemic heart disease.
Gulyás A; Szám I
Ther Hung; 1976; 24(2):63-6. PubMed ID: 982341
[No Abstract] [Full Text] [Related]
2. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
Parodi FA; Caputo G
Clin Ter; 1976 Dec; 79(6):571-81. PubMed ID: 1009761
[No Abstract] [Full Text] [Related]
3. [Effectiveness of pyridinolcarbamate in the overall treatment of infiltrative and cavernous-fibrous pulmonary tuberculosis].
Makinskiĭ AI; Safarov RN; Fondaminskaia LD; Semenova AS; Fedotova NN
Probl Tuberk; 1979 Jan; (1):26-30. PubMed ID: 368764
[No Abstract] [Full Text] [Related]
4. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy].
Citarrella P; Abbadessa V; Pecorella M; Cajozzo A
Boll Soc Ital Cardiol; 1977; 22(7):1036-41. PubMed ID: 618239
[No Abstract] [Full Text] [Related]
5. [Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
Fisanovich TI; Tolstova LG
Khirurgiia (Mosk); 1979 Sep; (9):76-80. PubMed ID: 502312
[No Abstract] [Full Text] [Related]
6. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
Roztocil K; Oliva I; Linhart J; Prerovský I; Modr Z
Cas Lek Cesk; 1976 Aug; 115(33-34):1051-5. PubMed ID: 975177
[No Abstract] [Full Text] [Related]
7. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
Tirkina TN; Aleksandrova LM; Kliachko VR; Mazovetskiĭ AG
Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
[No Abstract] [Full Text] [Related]
8. [Pyridinolcarbamate treatment of ischemic heart disease].
Kuz'ko NV
Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
[No Abstract] [Full Text] [Related]
9. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Pola P
Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
[No Abstract] [Full Text] [Related]
10. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Pola P
J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
[No Abstract] [Full Text] [Related]
11. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
Valiensi M; Riboli E; Lombardi M
Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
[No Abstract] [Full Text] [Related]
12. [Changes of the electrophoretic tracing of the serum glycoproteins in diabetic subjects treated with pyridinolcarbamate].
Notarbartolo A; Rini GB; Di Fede G
Boll Soc Ital Cardiol; 1973; 18(4):379-83. PubMed ID: 4807078
[No Abstract] [Full Text] [Related]
13. [Activity of the kallikrein-kinin system in patients with ischemic heart disease treated with parmidine].
Vygovskiĭ VP; Zaremba EF; Podil'chak EM; Dutka RIa; Gorgota OV
Vrach Delo; 1985 Sep; (9):6-8. PubMed ID: 2416131
[No Abstract] [Full Text] [Related]
14. The use of prodectin in the treatment of cerebral arteriosclerosis and its complications.
Abrányi I; Máté
Ther Hung; 1976; 24(1):20-3. PubMed ID: 790631
[No Abstract] [Full Text] [Related]
15. The effect of pyridinolcarbamate after acute and chronic administration in patients with atherosclerosis obliterans.
Roztocil K; Oliva J; Linhart J; Prerovský I; Modr Z
Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):135-8. PubMed ID: 844932
[TBL] [Abstract][Full Text] [Related]
16. [Effect of prodectin and lipoic acid on the lipid metabolism indicators in chronic ischemic heart disease].
Grigor'ian VA; Klantsa NA; Prishliak VD; Klantsa PN
Vrach Delo; 1981 Oct; (10):13-5. PubMed ID: 6795820
[No Abstract] [Full Text] [Related]
17. [Evaluation of the effectiveness of anginine treatment of diabetic microangiopathies].
Spesivtseva VG; Frenkel' VKh; Mamaeva GG; Sokolovskiĭ GA; Kukes VG
Sov Med; 1975 Jul; (7):42-5. PubMed ID: 1216049
[No Abstract] [Full Text] [Related]
18. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
Bagliani A; Borri P; Parravicini R
Minerva Cardioangiol; 1975 Nov; 23(11):701-10. PubMed ID: 1223674
[No Abstract] [Full Text] [Related]
19. Comparison of conservative (Prodectin) treatment and surgical intervention in arteriosclerotic obliterative diseases of the lower extremities.
Hunyi L
Ther Hung; 1978; 26(2):77-80. PubMed ID: 684660
[No Abstract] [Full Text] [Related]
20. Results obtained with prodectin in arteriosclerotic arterial obliteration of the lower extremities.
Hunyi L
Ther Hung; 1976; 24(2):67-71. PubMed ID: 982342
[No Abstract] [Full Text] [Related]
[Next] [New Search]
